Skip to main content
SpringerLink
Log in

Hypoglossal nerve stimulation cost effective in the UK for severe obstructive sleep apnoea

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The study was funded by Inspire Medical Systems.

Reference

  • Blissett DB, et al. Breathing Synchronised Hypoglossal Nerve Stimulation with Inspire for Untreated Severe Obstructive Sleep Apnoea/Hypopnoea Syndrome: A Simulated Cost-Utility Analysis from a National Health Service Perspective. PharmacoEconomics-Open : 28 Apr 2021. Available from: URL: https://doi.org/10.1007/s41669-021-00266-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hypoglossal nerve stimulation cost effective in the UK for severe obstructive sleep apnoea. PharmacoEcon Outcomes News 878, 13 (2021). https://doi.org/10.1007/s40274-021-7699-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7699-7

Search

Navigation